| OGN DMA Data | ||||||||||
Also see: |
| OGN DMA Chart |
  |
|
|
| About Organon & Co |
| Organon & Co. is a global health care company. Co. is engaged in developing and delivering health solutions through a portfolio of prescription therapies and medical devices within women's health, biosimilars and established brands. It has a portfolio of contraception and fertility brands, including Nexplanon, NuvaRing, and Follistim AQ. Co.'s Biosimilars portfolio spans across immunology and oncology treatments. It also has a portfolio of established brands, including brands in cardiovascular, respiratory, dermatology and non-opioid pain management. When researching a stock like Organon, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from OGN Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for OGN stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of those ways is to calculate a Simpe Moving Average ("SMA") by looking back a certain number of days. One of the most popular "longer look-backs" is the OGN 200 day moving average ("OGN 200 DMA"), while one of the most popular "shorter look-backs" is the OGN 50 day moving average ("OGN 50 DMA"). A chart showing both of these popular moving averages is shown on this page for Organon. |
| OGN Current Stock Quote |
Quotes delayed 20 minutes  Free OGN Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| OGN Stock Price Chart |
| Video: Technical Analysis | |
|
Video: Technical Analysis
| OGN DMA Peers |
OGN DMA | www.StockDMA.com | Copyright © 2019 - 2026, All Rights Reserved
Nothing in StockDMA.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.